Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats head lice infestations. NDA 22408, held by Cipher. Spinosad.
As of Nov 14, 2026, NDA 22408 (Natroba), held by Cipher, was first approved by FDA on Jan 18, 2011, with 3 approved supplements and 0 published complete response letters.
First approved: Jan 18, 2011
Review: Standard
Supplements approved: 3
Complete response letters: 0
What It's For
From the FDA-approved label (Indications and Usage)
Spinosad Topical Suspension is a pediculicide indicated for the topical treatment of head lice infestations in adult and pediatric patients 6 months of age and older. Spinosad Topical Suspension is a scabicide indicated for the topical treatment of scabies infestations in adult and pediatric patients 4 years of age and older. 1.1 Head Lice Infestations
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters.Drugs@FDA and FDA complete response letters
